655 related articles for article (PubMed ID: 31550244)
1. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
[TBL] [Abstract][Full Text] [Related]
2. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
[TBL] [Abstract][Full Text] [Related]
3. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
4. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
Idriss NK; Sayyed HG; Osama A; Sabry D
Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
[TBL] [Abstract][Full Text] [Related]
5. AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats.
Fathy M; Okabe M; Saad Eldien HM; Yoshida T
Molecules; 2020 Jan; 25(2):. PubMed ID: 31952158
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.
Shao CH; Chen SL; Dong TF; Chai H; Yu Y; Deng L; Wang Y; Cheng F
J Surg Res; 2014 Jan; 186(1):408-16. PubMed ID: 24071025
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
Mazhari S; Gitiara A; Baghaei K; Hatami B; Rad RE; Asadirad A; Joharchi K; Tokhanbigli S; Hashemi SM; Łos MJ; Aghdaei HA; Zali MR; Ghavami S
Eur J Pharmacol; 2020 Sep; 882():173263. PubMed ID: 32535098
[TBL] [Abstract][Full Text] [Related]
9. Advantages of adipose tissue stem cells over CD34
De Luna-Saldivar MM; Marino-Martinez IA; Franco-Molina MA; Rivera-Morales LG; Alarcón-Galván G; Cordero-Pérez P; Rojas-Martínez A; Rodríguez-Padilla C; Muñoz-Espinosa LE
Ann Hepatol; 2019; 18(4):620-626. PubMed ID: 31147180
[TBL] [Abstract][Full Text] [Related]
10. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W
Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132
[TBL] [Abstract][Full Text] [Related]
11. Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice.
Zhou YN; Sun MY; Mu YP; Yang T; Ning BB; Ren S; Chen JM; Liu P
J Ethnopharmacol; 2014 May; 153(3):659-66. PubMed ID: 24637190
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].
Lu W; Gao YH; Wang ZZ; Cai YS; Yang YQ; Miao YQ; Pei F; Liu XE; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):257-262. PubMed ID: 28494543
[No Abstract] [Full Text] [Related]
13. JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats.
Song SL; Gong ZJ; Huang YQ; Zhang QR; Huang TX
Am J Chin Med; 2006; 34(6):1047-61. PubMed ID: 17163593
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes.
Luo XY; Meng XJ; Cao DC; Wang W; Zhou K; Li L; Guo M; Wang P
Stem Cell Res Ther; 2019 Jan; 10(1):16. PubMed ID: 30635047
[TBL] [Abstract][Full Text] [Related]
16. [Effect of forsythiaside A against CCl_4-induced liver fibrosis in mice and its mechanism].
Guo Q; Zhang Y; Huang ZL; Lu B; Ji LL
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6137-6145. PubMed ID: 36471938
[TBL] [Abstract][Full Text] [Related]
17. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
Liu Y; Yang X; Jing Y; Zhang S; Zong C; Jiang J; Sun K; Li R; Gao L; Zhao X; Wu D; Shi Y; Han Z; Wei L
Sci Rep; 2015 Dec; 5():17762. PubMed ID: 26643997
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
Su DN; Wu SP; Xu SZ
Stem Cell Res Ther; 2020 Sep; 11(1):395. PubMed ID: 32928296
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
Motawi TM; Atta HM; Sadik NA; Azzam M
Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
[TBL] [Abstract][Full Text] [Related]
20. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.
Fang B; Shi M; Liao L; Yang S; Liu Y; Zhao RC
Transplantation; 2004 Jul; 78(1):83-8. PubMed ID: 15257043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
